The natural phosphoprotein phosphatase inhibitor cantharidin, primarily used for topical treatment of warts, has later been shown to trigger tumor cell apoptosis and is thus considered for the treatment of malignancy. Similar to apoptosis of tumor cells, erythrocytes may undergo eryptosis, a suicidal cell death characterized by cell shrinkage and translocation of cell membrane phosphatidylserine to the erythrocyte surface. Signaling of eryptosis includes increase of cytosolic Ca shrinkage and erythrocyte membrane scrambling, an effect sensitive to kinase inhibitors staurosporine and skepinone.
Introduction
Cantharidin, a traditional Chinese natural product, has been successfully used for the treatment of warts, molluscum contagiosum, and callus removal [1] . Cantharidin and its demethylated analogue norcantharidin have more recently been shown to be effective against malignancy [2] [3] [4] . The anticancer effects are in part attributed to their inhibitory effect on phosphoprotein phosphatases [4, 5] and stimulation of tumor cell apoptosis [6] [7] [8] [9] . Further mechanisms invoked in (nor) cantheridine induced apoptosis include mitochondrial dysregulation [10, 11] , cytosolic cytochrome c release [3] , activation of caspase-9 [3, 12] , induction of oxidative stress [10, 13] and activation of the transcription factor p53 with subsequent triggering of p53 dependent gene expression [13, 14] .
Erythrocytes lack mitochondria and nuclei, but are nevertheless able to enter suicidal cell death or eryptosis, which is characterized by cell shrinkage [15] and translocation of phosphatidylserine to the outer surface of the erythrocyte cell membrane [16] . Signaling involved in the stimulation of eryptosis includes increased cytosolic Ca 2+ activity ([Ca 2+ ]i), ceramide [17] , oxidative stress [16] , caspase activation [16, 18, 19] , activation of casein kinase 1α, Janus-activated kinase JAK3, protein kinase C, p38 kinase, and PAK2 kinase [16] or inhibition of AMP activated kinase AMPK, cGMP-dependent protein kinase, and sorafenib and sunitinib sensitive kinases [16] . Eryptosis is triggered by a wide variety of xenobiotics [16, .
The present study explored whether cantharidin stimulates eryptosis. To this end, erythrocytes from healthy volunteers were exposed to cantharidin, phosphatidylserine abundance at the erythrocyte surface determined using annexin-V-binding and cell volume estimated from forward scatter in flow cytometry. Moreover, [Ca 2+ ]i was estimated utilizing Fluo3-fluorescence, ceramide abundance utilizing specific antibodies, and abundance of reactive oxidant species utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) fluorescence. The involvement of phosphorylation was tested utilizing kinase inhibitors staurosporine and skepinone.
Results and Discussion
The present study explored whether cantharidin is capable to trigger eryptosis, the suicidal death of erythrocytes, i.e., of cells lacking mitochondria and nuclei, organelles considered to play a major role in the triggering of apoptosis. Hallmarks of eryptosis are phosphatidylserine translocation to the cell surface and cell shrinkage.
Phosphatidylserine at the cell surface was detected utilizing binding of FITC-labeled annexin-V to phosphatidylserine. The abundance of FITC-labeled annexin-V was determined by flow cytometry. As illustrated in Figure 1 , a 48 h exposure to cantharidin enhanced the percentage of annexin-V-binding erythrocytes, an effect reaching statistical significance at 10 g/mL cantharidin concentration. As shown in Figure 1 , cantharidin did not modify hemolysis. Forward scatter was determined in flow cytometry as a measure of erythrocyte cell volume. As shown in Figure 2 , a 48 h cantharidin treatment was followed by a decrease of erythrocyte forward scatter, an effect reaching statistical significance at 25 g/mL cantharidin concentration. ]i). As illustrated in Figure 3A ,B, a 48 h exposure to cantharidin increased the Fluo3 fluorescence, an effect requiring 25 g/mL cantharidin concentration for statistical significance. To test the effect of calcium concentration in the staining solution while loading with Fluo3 and to test the potential toxic effects from released formaldehyde as a byproduct of esterification [43, 44] , we treated erythrocytes for 48 h with Ringer solution without or with cantharidin (50 g/mL) and then stained for 30 min with Fluo3 AM in Ringer solution containing 1 or 5 mM CaCl2 in the presence and absence of 1 mM sodium pyruvate.
As illustrated in Figure 3D , the stimulatory effect of cantharidin on Fluo3 staining, in the presence of 1 or 5 mM CaCl2, was similar in the presence or absence of pyruvate. A further series of experiments explored whether cantharidin-induced translocation of phosphatidylserine to the cell surface required entry of extracellular Ca
2+
. To this end, erythrocytes were incubated for 48 h in the absence or presence of 25 or 50 g/mL cantharidin, both in the presence or nominal absence of extracellular Ca ]i by ceramide. Thus, specific antibodies were utilized to quantify ceramide abundance at the erythrocyte surface. As a result, the ceramide abundance was similar following a 48 h incubation in the absence of cantharidin (11.3 ± 1.3 a.u., n = 9), presence of 10 g/mL cantharidin (11.1 ± 1.4 a.u., n = 9) and presence of 50 g/mL cantharidin (11.2 ± 1.5 a.u., n = 9). Thus, cantharidin did not enhance ceramide abundance.
Additional experiments explored whether cantharidin influences the formation of reactive oxygen species (ROS). To this end, ROS was quantified utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA). As shown in Figure 4 , a 48 h exposure to cantharidin (50 g/mL) did not modify DCFDA fluorescence. As a positive control, a 48 h exposure to tert-butyl-hydroperoxide (100 M, tBOOH) was followed by a strong and highly significant increase of DCFDA fluorescence (Figure 4 ). In order to test whether the effect of cantharidin was related to protein phosphorylation, the effect of cantharidin on translocation of phosphatidylserine to the cell surface was determined in the absence and presence of protein kinase inhibitor staurosporine (1 M). Erythrocytes were incubated for 48 h in the absence or presence of 50 g/mL cantharidin, both in the absence or presence of staurosporine (1 M). Addition of staurosporine fully abrogated the effect of cantharidin on annexin-V-binding ( Figure 5A ) and abrogated the effect of cantharidin on forward scatter ( Figure 5B ). Additional experiments explored whether cantharidin effect was influenced by the protein kinase inhibitor skepinone. Erythrocytes were incubated for 48 h in the absence or presence of 50 g/mL cantharidin, both in the absence or presence of skepinone (2 M). Addition of skepinone slightly inhibited the effect of cantharidin on annexin-V-binding, but did not inhibit the effect of cantharidin on forward scatter (Figure 6 ).
The present observations reveal a novel effect of cantharidin, i.e., the triggering of erythrocyte shrinkage and erythrocyte cell membrane scrambling with phosphatidylserine translocation from the cell interior to the erythrocyte surface. Cell membrane scrambling and cell shrinkage are the hallmarks of eryptosis, the suicidal erythrocyte death. In contrast to its effect on eryptosis, cantharidin did not induce appreciable hemolysis. The cantharidin concentration required for stimulation of erythrocyte cell membrane scrambling (10 g/mL) was in the range of cantharidin concentrations required to elicit tumor cell apoptosis (IC50 ≈ 20 M ≈ 4 g/mL) [7] but higher than those reported in rats (~0.1 g/mL) [45] and dogs (~0.15 g/mL) [46] . At higher concentrations, cantharidin increases cytosolic Ca insensitive mechanism. Such a mechanism could have been ceramide. However, the cantharidin-induced eryptosis does apparently not involve ceramide formation or translocation.
Cantharidin further did not trigger oxidative stress, a known stimulator of eryptosis [16] . In nucleated cells, cantharidin does induce oxidative stress [10, 13] , an effect presumably requiring mitochondria [10, 11] and thus lacking in erythrocytes.
Instead, the effect of cantharidin on both, cell membrane scrambling and cell volume was apparently related to its inhibitory effect on phosphoprotein phosphatases [4, 5] . The effect of cantharidin on both, cell membrane scrambling and cell volume, was completely abrogated by the kinase inhibitor staurosporine. It is tempting to speculate that cantharidin prevents dephosphorylation of target proteins, which are phosphorylated by staurosporine sensitive kinases. Regulators of erythrocyte cell volume include KCl symport on the one hand and Na
− cotransport on the other, carriers under the control of several kinases [47] [48] [49] . Thus, deranged activity of those kinases or carriers could contribute to cell volume loss.
Cell shrinkage and loss of cellular K + in turn fosters cell membrane scrambling [15] . The sensitivity of cantharidin induced eryptosis to staurosporine and skepinone indeed suggests a role of kinases in the triggering of eryptosis. Staurosporine completely abrogated the effect of cantharidin on both, phosphatidylserine translocation and cell volume, whereas skepinone only slightly blunted the effect of cantharidin on phosphatidylserine translocation and did not appreciably modify the cantharidin-induced cell shrinkage. Apparently, p38 kinase contributes to but does not account for cantharidine-induced eryptosis. Clearly, additional experimental effort is required to dissect the specific kinase(s) and phosphatase(s) involved in the cantharidin sensitive regulation of eryptosis.
The stimulation of eryptosis by cantharidin may add to the toxicity of the substance. Phosphatidylserine exposing erythrocytes are engulfed by macrophages and thus rapidly cleared from circulating blood and stimulation of eryptosis may thus lead to anemia [16] . Moreover, erythrocytes exposing phosphatidylserine at their surface may adhere to endothelial cells of the vascular wall [50] , stimulate blood clotting and induce thrombosis [51] [52] [53] . Accordingly, stimulating phosphatidylserine exposure of erythrocytes may impede microcirculation [17, 51, [54] [55] [56] [57] . The toxic effect may be augmented in clinical conditions associated with enhanced eryptosis, such as malignancy, hepatic failure, diabetes, uremia, hemolytic uremic syndrome, sepsis, fever, dehydration, mycoplasma infection, malaria, iron deficiency, sickle cell anemia, thalassemia, glucose-6-phosphate dehydrogenase deficiency, and Wilson's disease [16] .
Experimental Section

Erythrocytes, Solutions and Chemicals
Fresh Lithium-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study was approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 23 °C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro for 48 h at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 glucose, and 1 CaCl2; the pH was adjusted to 7.4 and the temperature kept at 37 °C. Where indicated, erythrocytes were exposed to cantharidin (Sigma Aldrich, Hamburg, Germany).
Annexin-V-Binding and Forward Scatter
After incubation under the respective experimental condition, a 150 L cell suspension was washed in Ringer solution containing 5 mM CaCl2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37 °C for 20 min under protection from light. In the following, the geometric mean of the forward scatter (FSC) was determined, and annexin-V fluorescence intensity was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD, Heidelberg, Germany). In some experiments erythrocytes were preincubated in Ca 2+ free solution. For determination of annexin-V-binding, addition of Ca 2+ was required during the 15 min incubation with FITC-annexin-V. Immediately thereafter measurements were done so that the exposure to Ca 2+ was too short to trigger significant phosphatidylserine translocation.
Hemolysis
For the determination of hemolysis, the samples were centrifuged (3 min at 1600 rpm, room temperature) after incubation under the respective experimental conditions and the supernatants were harvested. As a measure of hemolysis, the hemoglobin (Hb) concentration of the supernatant was determined photometrically at 405 nm. The absorption of the supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis.
Intracellular Ca
2+
After incubation, a 150 L cell suspension was washed in Ringer solution and then loaded with 
Reactive Oxidant Species (ROS)
Oxidative stress was determined utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 150 L suspension of erythrocytes was washed in Ringer solution and then stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 M. Erythrocytes were incubated at 37 °C for 30 min in the dark and then washed three times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 L Ringer solution, and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD).
Ceramide Abundance
For the determination of ceramide, a monoclonal antibody-based assay was used. After incubation, cells were stained for 1 h at 37 °C with 1 g/mL anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice with PBS-BSA. Subsequently, the cells were stained for 30 min with polyclonal fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples were then analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey's test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
Conclusions
Cantharidin stimulates erythrocyte cell membrane scrambling and cell shrinkage, both hallmarks of eryptosis, the suicidal erythrocyte death. The effect of cantharidin on cell membrane scrambling and cell shrinkage is abrogated by kinase inhibitor staurosporine and may thus be due to the known inhibitory effect of cantharidin on protein phosphatases.
